|
Vaccine Detail
PrV-HA (swine-origin H1N1) |
Vaccine Information |
- Vaccine Name: PrV-HA (swine-origin H1N1)
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004698
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- HA
gene engineering:
- Type: Recombinant protein preparation
- Description: Pseudorabies virus (PrV) strain Bartha (PrV-Ba) served as a vector for the expression of haemagglutinin (HA) of swine-origin H1N1 virus (Klingbeil et al., 2014).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: The pseudorabies virus (PrV) strain Bartha (PrV-Ba) was used as vector for the expression of haemagglutinin (HA) of swine-origin H1N1 virus (Klingbeil et al., 2014).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Pig Response
- Vaccination Protocol: Piglets were infected intranasally with PrV-BaMI-synH1 as a live-virus vaccine, whereas control animals were immunized with PrV-Ba or not vaccinated (Klingbeil et al., 2014).
- Vaccine Immune Response Type: VO_0003057
- Challenge Protocol: A challenge with pandemic H1N1 SoIV A/California/7/09 performed 3 weeks after immunization (Klingbeil et al., 2014).
- Efficacy: A single immunization of pigs with the PrV vector expressing the codon-optimized HA gene under control of P-MCMV induced high levels of HA-specific antibodies (Klingbeil et al., 2014).
|
References |
Klingbeil et al., 2014: Klingbeil K, Lange E, Teifke JP, Mettenleiter TC, Fuchs W. Immunization of pigs with an attenuated pseudorabies virus recombinant expressing the haemagglutinin of pandemic swine origin H1N1 influenza A virus. The Journal of general virology. 2014; 95(Pt 4); 948-959. [PubMed: 24431235].
|
|